CM Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

CM Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-800,000	Closed	-$768K	–	75
2023 Q2	$768K	Buy	800,000 +125,000	+19%	+$124K	0.75%	43
2023 Q1	$506K	Hold	675,000	–	–	0.6%	45
2022 Q4	$249K	Sell	675,000 -125,000	-16%	-$52.7K	0.3%	61
2022 Q3	$344K	Buy	800,000 +200,000	+33%	+$197K	0.38%	63
2022 Q2	$468K	Hold	600,000	–	–	0.5%	58
2022 Q1	$774K	Buy	600,000 +450,000	+300%	+$414K	0.65%	52
2021 Q4	$191K	Sell	150,000 -150,000	-50%	-$268K	0.14%	88
2021 Q3	$654K	Hold	300,000	–	–	0.49%	65
2021 Q2	$1.13M	Hold	300,000	–	–	0.81%	49
2021 Q1	$978K	Buy	300,000 +50,000	+20%	+$179K	0.73%	60
2020 Q4	$853K	Buy	+250,000	New	+$1.03M	0.79%	46

CM Management's SPPI Position: Q3 2023 in Review

CM Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 800,000 shares — an estimated $768K sold.

CM Management first reported a position in SPPI in Q4 2020 and held it in 11 quarters. The position peaked at $1.13M in Q2 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

CM Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
CM Management sold 800,000 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $768K.
CM Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2020 and held it in 11 quarters.
CM Management's Spectrum Pharmaceuticals Inc position peaked at $1.13M in Q2 2021.
0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on CM Management's 13F filing for Q3 2023, filed 7 Nov 2023.